id stringlengths 11 11 | tags stringlengths 10 777 | text stringlengths 2 1.5k | dataset_num int64 1 3 | tokens list | ner_tags list |
|---|---|---|---|---|---|
NCT02833792 | 12:24:chronic_disease,26:34:chronic_disease,39:62:chronic_disease | History of intracranial, subdural, or subarachnoid hemorrhage | 2 | [
"History",
"of",
"intracranial",
",",
"subdural",
",",
"or",
"subarachnoid",
"hemorrhage"
] | [
0,
0,
2,
0,
2,
0,
0,
2,
2
] |
NCT02991144 | 18:96:treatment, | Participation in another investigational medicine study (including another gene transfer trial) within 3 months of Screening | 2 | [
"Participation",
"in",
"another",
"investigational",
"medicine",
"study",
"(",
"including",
"another",
"gene",
"transfer",
"trial",
")",
"within",
"3",
"months",
"of",
"Screening"
] | [
0,
0,
1,
1,
1,
1,
1,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT02208362 | 74:90:chronic_disease,132:143:chronic_disease,147:148:chronic_disease,239:253:treatment | Research participants with any uncontrolled illness including ongoing or active infection; research participants with known active hepatitis B or C infection; research participants with any signs or symptoms of active infection, positive blood cultures or radiological evidence of infections | 2 | [
"Research",
"participants",
"with",
"any",
"uncontrolled",
"illness",
"including",
"ongoing",
"or",
"active",
"infection",
";",
"research",
"participants",
"with",
"known",
"active",
"hepatitis",
"B",
"or",
"C",
"infection",
";",
"research",
"participants",
"with",
... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
2,
2,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0
] |
NCT01220583 | 4:26:treatment | No prior organ transplant | 2 | [
"No",
"prior",
"organ",
"transplant"
] | [
0,
1,
1,
1
] |
NCT02891850 | 17:33:chronic_disease | Patients with a medical disorder, condition, or history | 2 | [
"Patients",
"with",
"a",
"medical",
"disorder",
",",
"condition",
",",
"or",
"history"
] | [
0,
0,
0,
2,
2,
0,
0,
0,
0,
0
] |
NCT02466126 | 1:21:chronic_disease | cognitive impairment | 2 | [
"cognitive",
"impairment"
] | [
2,
2
] |
NCT03179163 | 10:18:treatment | taking a diuretic | 2 | [
"taking",
"a",
"diuretic"
] | [
0,
0,
1
] |
NCT02030015 | 33:42:allergy_name | Subjects who have an allergy to miglustat or any of the components within the drug product | 2 | [
"Subjects",
"who",
"have",
"an",
"allergy",
"to",
"miglustat",
"or",
"any",
"of",
"the",
"components",
"within",
"the",
"drug",
"product"
] | [
0,
0,
0,
0,
0,
0,
4,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02930018 | 1:11:treatment, | Study drug intended to be administered within 60 minutes of the baseline/qualifying NCCT | 2 | [
"Study",
"drug",
"intended",
"to",
"be",
"administered",
"within",
"60",
"minutes",
"of",
"the",
"baseline/qualifying",
"NCCT"
] | [
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02131467 | 1:11:treatment | nevirapine | 2 | [
"nevirapine"
] | [
1
] |
NCT01822522 | 1:17:chronic_disease,28:46:treatment,37:46:treatment, | Active infection requiring systemic treatment within 28 days before the first dose of study treatment | 2 | [
"Active",
"infection",
"requiring",
"systemic",
"treatment",
"within",
"28",
"days",
"before",
"the",
"first",
"dose",
"of",
"study",
"treatment"
] | [
2,
2,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02530463 | 15:18:cancer, | Patients with MDS (up to 20% blasts) of any risk as defined as | 2 | [
"Patients",
"with",
"MDS",
"(",
"up",
"to",
"20",
"%",
"blasts",
")",
"of",
"any",
"risk",
"as",
"defined",
"as"
] | [
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02680145 | 9:27:chronic_disease | Have an isolated rectocele | 2 | [
"Have",
"an",
"isolated",
"rectocele"
] | [
0,
0,
2,
2
] |
NCT03145298 | 14:17:chronic_disease,29:33:chronic_disease,35:39:chronic_disease,41:48:chronic_disease,52:59:chronic_disease | Diagnosis of PAH other than IPAH, HPAH, PAH-CTD or PAH-HIV | 2 | [
"Diagnosis",
"of",
"PAH",
"other",
"than",
"IPAH",
",",
"HPAH",
",",
"PAH-CTD",
"or",
"PAH-HIV"
] | [
0,
0,
2,
0,
0,
2,
0,
2,
0,
2,
0,
2
] |
NCT02347111 | 1:3:chronic_disease, | AF symptoms present at least once per month | 2 | [
"AF",
"symptoms",
"present",
"at",
"least",
"once",
"per",
"month"
] | [
2,
0,
0,
0,
0,
0,
0,
0
] |
NCT02565498 | 13:35:chronic_disease | Presence of regional nodal disease or unequivocal distant metastases | 2 | [
"Presence",
"of",
"regional",
"nodal",
"disease",
"or",
"unequivocal",
"distant",
"metastases"
] | [
0,
0,
2,
2,
2,
0,
0,
0,
0
] |
NCT02362997 | 39:62:treatment,74:86:treatment,88:100:treatment,104:117:treatment,125:129:treatment | Participants cannot have received any anti-neoplastic therapy (including radiotherapy, chemotherapy or immunotherapy) after ASCT | 2 | [
"Participants",
"can",
"not",
"have",
"received",
"any",
"anti-neoplastic",
"therapy",
"(",
"including",
"radiotherapy",
",",
"chemotherapy",
"or",
"immunotherapy",
")",
"after",
"ASCT"
] | [
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
1,
0,
1,
0,
1,
0,
0,
1
] |
NCT02551679 | 7:13:chronic_disease | Major stroke | 2 | [
"Major",
"stroke"
] | [
0,
2
] |
NCT02579967 | 40:60:treatment,68:96:treatment,131:138:chronic_disease | MagT1 mutation and active need to take anti-platelet agents and/or therapeutic anti-coagulation that cannot be interrupted during aplasia | 2 | [
"MagT1",
"mutation",
"and",
"active",
"need",
"to",
"take",
"anti-platelet",
"agents",
"and/or",
"therapeutic",
"anti-coagulation",
"that",
"can",
"not",
"be",
"interrupted",
"during",
"aplasia"
] | [
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
1,
1,
0,
0,
0,
0,
0,
0,
2
] |
NCT03053453 | 1:38:treatment | Contralateral Total Knee Arthroplasty | 2 | [
"Contralateral",
"Total",
"Knee",
"Arthroplasty"
] | [
1,
1,
1,
1
] |
NCT01684397 | 13:46:chronic_disease | Symptomatic peripheral arterial disease (PAD) | 2 | [
"Symptomatic",
"peripheral",
"arterial",
"disease",
"(",
"PAD",
")"
] | [
0,
2,
2,
2,
2,
0,
0
] |
NCT01589263 | 32:57:cancer,61:68:cancer,70:86:treatment,90:97:treatment,99:117:chronic_disease,122:146:treatment | History or current evidence of carcinoma of the prostate or bladder, pelvic radiation or surgery, urethral stricture, or bladder neck obstruction | 2 | [
"History",
"or",
"current",
"evidence",
"of",
"carcinoma",
"of",
"the",
"prostate",
"or",
"bladder",
",",
"pelvic",
"radiation",
"or",
"surgery",
",",
"urethral",
"stricture",
",",
"or",
"bladder",
"neck",
"obstruction"
] | [
0,
0,
0,
0,
0,
3,
3,
3,
3,
0,
1,
1,
1,
1,
0,
1,
0,
2,
2,
0,
0,
0,
0,
0
] |
NCT03118973 | 1:17:chronic_disease,19:31:chronic_disease,59:83:treatment | Thrombocytopenia, coagulopathy, or indication for ongoing anti-coagulation therapy | 2 | [
"Thrombocytopenia",
",",
"coagulopathy",
",",
"or",
"indication",
"for",
"ongoing",
"anti-coagulation",
"therapy"
] | [
2,
0,
2,
0,
0,
0,
0,
0,
1,
1
] |
NCT02515513 | 30:48:treatment | do not meet the criteria for surgical resection | 2 | [
"do",
"not",
"meet",
"the",
"criteria",
"for",
"surgical",
"resection"
] | [
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT03045341 | 18:45:treatment | Currently taking anti-depressant medications | 2 | [
"Currently",
"taking",
"anti-depressant",
"medications"
] | [
0,
0,
1,
1
] |
NCT02081404 | 21:27:cancer,, | recent diagnosis of cancer with a life-expectancy < 5 years | 2 | [
"recent",
"diagnosis",
"of",
"cancer",
"with",
"a",
"life-expectancy",
"<",
"5",
"years"
] | [
0,
0,
0,
3,
0,
0,
0,
0,
0,
0
] |
NCT02862938 | 37:53:treatment, | Participant is likely to be offered glaucoma surgery within 6 months of screening | 2 | [
"Participant",
"is",
"likely",
"to",
"be",
"offered",
"glaucoma",
"surgery",
"within",
"6",
"months",
"of",
"screening"
] | [
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0
] |
NCT01696734 | 1:14:chronic_disease, | GI hemorrhage or obstruction experienced within the previous 6 weeks | 2 | [
"GI",
"hemorrhage",
"or",
"obstruction",
"experienced",
"within",
"the",
"previous",
"6",
"weeks"
] | [
2,
2,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02772562 | 1:23:cancer | pN1 lymph node disease | 2 | [
"pN1",
"lymph",
"node",
"disease"
] | [
3,
3,
3,
3
] |
NCT02595866 | 12:23:chronic_disease,47:68:treatment,197:210:chronic_disease | A positive hepatitis B serology indicative of previous immunization (i.e., hepatitis B surface antibody [HBsAb] positive and hepatitis B core antibody [HBcAb] negative), or a fully resolved acute HBV infection | 2 | [
"A",
"positive",
"hepatitis",
"B",
"serology",
"indicative",
"of",
"previous",
"immunization",
"(",
"i.e.",
",",
"hepatitis",
"B",
"surface",
"antibody",
"[",
"HBsAb",
"]",
"positive",
"and",
"hepatitis",
"B",
"core",
"antibody",
"[",
"HBcAb",
"]",
"negative",... | [
0,
0,
2,
2,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2
] |
NCT02433977 | 1:17:treatment,28:34:chronic_disease,45:58:treatment,60:78:treatment | Systemic steroid dependent asthma (no daily oral steroids- short term therapy for asthma exacerbation is permitted) | 2 | [
"Systemic",
"steroid",
"dependent",
"asthma",
"(",
"no",
"daily",
"oral",
"steroids-",
"short",
"term",
"therapy",
"for",
"asthma",
"exacerbation",
"is",
"permitted",
")"
] | [
1,
1,
0,
2,
0,
0,
0,
1,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0
] |
NCT02473250 | 1:11:chronic_disease,, | Depression of sufficient severity to score at least 16 on the first 17 items of the Hamilton Depression Rating Scale | 2 | [
"Depression",
"of",
"sufficient",
"severity",
"to",
"score",
"at",
"least",
"16",
"on",
"the",
"first",
"17",
"items",
"of",
"the",
"Hamilton",
"Depression",
"Rating",
"Scale"
] | [
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02507011 | 1:12:chronic_disease,, | Hypotension defined as systolic blood pressure < 100 mmHg at the time of enrollment | 2 | [
"Hypotension",
"defined",
"as",
"systolic",
"blood",
"pressure",
"<",
"100",
"mmHg",
"at",
"the",
"time",
"of",
"enrollment"
] | [
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02281409 | 26:29:chronic_disease,31:42:chronic_disease,44:55:chronic_disease | An existing diagnosis of HIV, hepatitis B, hepatitis C, or any current laboratory findings or clinical signs and symptoms that suggest these conditions | 2 | [
"An",
"existing",
"diagnosis",
"of",
"HIV",
",",
"hepatitis",
"B",
",",
"hepatitis",
"C",
",",
"or",
"any",
"current",
"laboratory",
"findings",
"or",
"clinical",
"signs",
"and",
"symptoms",
"that",
"suggest",
"these",
"conditions"
] | [
0,
0,
0,
0,
2,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02472834 | 90:108:treatment | Willing and able to adhere to all study-related procedures, including adherence to study medication regimen | 2 | [
"Willing",
"and",
"able",
"to",
"adhere",
"to",
"all",
"study-related",
"procedures",
",",
"including",
"adherence",
"to",
"study",
"medication",
"regimen"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02078102 | 49:69:chronic_disease, | Patients must not have nor had active or recent peptic ulcer disease within the past 6 months | 2 | [
"Patients",
"must",
"not",
"have",
"nor",
"had",
"active",
"or",
"recent",
"peptic",
"ulcer",
"disease",
"within",
"the",
"past",
"6",
"months"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0
] |
NCT02953860 | 1:18:treatment | Vaginal estrogens are allowed if necessary for patient comfort | 2 | [
"Vaginal",
"estrogens",
"are",
"allowed",
"if",
"necessary",
"for",
"patient",
"comfort"
] | [
1,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT02457832 | 1:22:chronic_disease | Peripheral neuropathy | 2 | [
"Peripheral",
"neuropathy"
] | [
2,
2
] |
NCT02341209 | 75:95:treatment,, | The subject has resolution of all clinically significant toxic effects of prior cancer therapy to Grade ≤1 by the National Cancer Institute Common Terminology Criteria for Adverse Events | 2 | [
"The",
"subject",
"has",
"resolution",
"of",
"all",
"clinically",
"significant",
"toxic",
"effects",
"of",
"prior",
"cancer",
"therapy",
"to",
"Grade",
"≤1",
"by",
"the",
"National",
"Cancer",
"Institute",
"Common",
"Terminology",
"Criteria",
"for",
"Adverse",
"... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02414139 | 11:20:treatment | Cohort 5: Treatment-naïve patients with cMET dysregulation | 2 | [
"Cohort",
"5",
":",
"Treatment-naïve",
"patients",
"with",
"cMET",
"dysregulation"
] | [
0,
0,
0,
1,
0,
0,
0,
0
] |
NCT02393794 | 52:69:treatment,94:117:cancer,168:180:treatment,207:223:treatment | Participants who have previously been treated with endocrine therapy only, and later develop triple negative disease are eligible as long as they have had one line of chemotherapy in either the advanced or adjuvant setting | 2 | [
"Participants",
"who",
"have",
"previously",
"been",
"treated",
"with",
"endocrine",
"therapy",
"only",
",",
"and",
"later",
"develop",
"triple",
"negative",
"disease",
"are",
"eligible",
"as",
"long",
"as",
"they",
"have",
"had",
"one",
"line",
"of",
"chemoth... | [
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
1,
1
] |
NCT02460835 | ,,122:128:cancer,, | Zubrod performance status of less than or equal to 2 (Zubrod performance status is a measure that attempts to quantify a cancer patients' general well-being. Scores run from 0 to 5 where 0 denotes normal activity and 5 denotes death) | 2 | [
"Zubrod",
"performance",
"status",
"of",
"less",
"than",
"or",
"equal",
"to",
"2",
"(",
"Zubrod",
"performance",
"status",
"is",
"a",
"measure",
"that",
"attempts",
"to",
"quantify",
"a",
"cancer",
"patients",
"'",
"general",
"well-being",
".",
"Scores",
"ru... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02926248 | 15:28:chronic_disease | Patients with renal disease | 2 | [
"Patients",
"with",
"renal",
"disease"
] | [
0,
0,
2,
2
] |
NCT02665338 | 1:17:chronic_disease | Major Depression | 2 | [
"Major",
"Depression"
] | [
2,
2
] |
NCT02416206 | 14:30:cancer | Diagnosis of Multiple Myeloma | 2 | [
"Diagnosis",
"of",
"Multiple",
"Myeloma"
] | [
0,
0,
3,
3
] |
NCT02340650 | 17:32:chronic_disease | Patients having acute infection | 2 | [
"Patients",
"having",
"acute",
"infection"
] | [
0,
0,
2,
2
] |
NCT02746458 | 84:100:treatment | Use of blood flow restriction (BFR) at any time between treatment and the start of physical therapy for the study | 2 | [
"Use",
"of",
"blood",
"flow",
"restriction",
"(",
"BFR",
")",
"at",
"any",
"time",
"between",
"treatment",
"and",
"the",
"start",
"of",
"physical",
"therapy",
"for",
"the",
"study"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0
] |
NCT02518594 | 12:24:allergy_name,26:34:allergy_name,57:67:treatment,79:86:allergy_name,90:100:allergy_name,122:129:allergy_name | Allergy to progesterone, silicone, or excipients in the study drug, including peanuts or peanut oil in the study drug or placebo | 2 | [
"Allergy",
"to",
"progesterone",
",",
"silicone",
",",
"or",
"excipients",
"in",
"the",
"study",
"drug",
",",
"including",
"peanuts",
"or",
"peanut",
"oil",
"in",
"the",
"study",
"drug",
"or",
"placebo"
] | [
0,
0,
4,
0,
4,
0,
0,
0,
0,
0,
1,
1,
0,
0,
4,
0,
4,
4,
0,
0,
0,
0,
0,
4
] |
NCT02525029 | 9:31:chronic_disease,52:67:treatment,89:114:treatment | Current thromboembolic disease requiring full-dose anticoagulation - patients receiving pharmacologic prophylaxis for thromboembolic disease will be eligible | 2 | [
"Current",
"thromboembolic",
"disease",
"requiring",
"full-dose",
"anticoagulation",
"-",
"patients",
"receiving",
"pharmacologic",
"prophylaxis",
"for",
"thromboembolic",
"disease",
"will",
"be",
"eligible"
] | [
0,
2,
2,
0,
0,
1,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0
] |
NCT02312518 | 88:106:treatment,124:129:chronic_disease,162:196:treatment | Subject requires or is anticipated to require interventions directed at improvement of arterial perfusion to affected area Ulcer expected to be treated with any advanced therapeutics (e.g., HBOT) | 2 | [
"Subject",
"requires",
"or",
"is",
"anticipated",
"to",
"require",
"interventions",
"directed",
"at",
"improvement",
"of",
"arterial",
"perfusion",
"to",
"affected",
"area",
"Ulcer",
"expected",
"to",
"be",
"treated",
"with",
"any",
"advanced",
"therapeutics",
"("... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
0,
0,
0
] |
NCT02387216 | 73:87:cancer,112:130:cancer,,,192:199:treatment | Patients with a diagnosis of cytologically or histologically documented adenocarcinoma of the lung with either metastatic disease (stage IV), Stage IIIB or Stage IIIC disease not amenable to surgery with curative intent | 2 | [
"Patients",
"with",
"a",
"diagnosis",
"of",
"cytologically",
"or",
"histologically",
"documented",
"adenocarcinoma",
"of",
"the",
"lung",
"with",
"either",
"metastatic",
"disease",
"(",
"stage",
"IV",
")",
",",
"Stage",
"IIIB",
"or",
"Stage",
"IIIC",
"disease",
... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
0,
0,
0,
0,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0
] |
NCT02418195 | 16:32:chronic_disease | only childhood febrile seizures | 2 | [
"only",
"childhood",
"febrile",
"seizures"
] | [
0,
0,
2,
2
] |
NCT02169739 | 10:23:chronic_disease,41:56:treatment,75:82:treatment | No major cardioembolic source requiring anticoagulation or other specific therapy | 2 | [
"No",
"major",
"cardioembolic",
"source",
"requiring",
"anticoagulation",
"or",
"other",
"specific",
"therapy"
] | [
0,
0,
2,
0,
0,
1,
0,
0,
0,
1
] |
NCT01705119 | 22:43:chronic_disease | Evidence of elevated intracranial pressure | 2 | [
"Evidence",
"of",
"elevated",
"intracranial",
"pressure"
] | [
0,
0,
0,
2,
2
] |
NCT02389517 | 29:41:treatment,, | Patients must have received lenalidomide maintenance for 3 months (+1 month window for a maximum of 4 months lenalidomide prior to enrollment) | 2 | [
"Patients",
"must",
"have",
"received",
"lenalidomide",
"maintenance",
"for",
"3",
"months",
"(",
"+1",
"month",
"window",
"for",
"a",
"maximum",
"of",
"4",
"months",
"lenalidomide",
"prior",
"to",
"enrollment",
")"
] | [
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02472834 | 13:19:chronic_disease | Presence of asthma | 2 | [
"Presence",
"of",
"asthma"
] | [
0,
0,
2
] |
NCT03089281 | 21:29:treatment | currently requiring dialysis | 2 | [
"currently",
"requiring",
"dialysis"
] | [
0,
0,
1
] |
NCT02186418 | 34:56:chronic_disease,58:61:chronic_disease,72:95:treatment | Patients with medical history of pulmonary hypertension, PHT proved by cardiac catheterization | 2 | [
"Patients",
"with",
"medical",
"history",
"of",
"pulmonary",
"hypertension",
",",
"PHT",
"proved",
"by",
"cardiac",
"catheterization"
] | [
0,
0,
0,
0,
0,
2,
2,
0,
2,
0,
0,
1,
1
] |
NCT02419495 | 35:55:chronic_disease,158:181:chronic_disease,218:256:chronic_disease,260:310:chronic_disease,311:343:chronic_disease,370:400:chronic_disease,,,453:479:chronic_disease, | Unstable cardiovascular function: symptomatic ischemia (chest pain of cardiac origin), or uncontrolled clinically significant conduction abnormalities (e.g. ventricular tachycardia on antiarrhythmics are excluded and 1st degree atrioventricular [AV] block or asymptomatic left anterior fascicular block [LAFB]/right bund... | 2 | [
"Unstable",
"cardiovascular",
"function",
":",
"symptomatic",
"ischemia",
"(",
"chest",
"pain",
"of",
"cardiac",
"origin",
")",
",",
"or",
"uncontrolled",
"clinically",
"significant",
"conduction",
"abnormalities",
"(",
"e.g",
".",
"ventricular",
"tachycardia",
"on"... | [
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
2,
2,
2,
2,
2,
0,
0,
0,
2,
2,
2,
2,
2,
2,
0,
0,
2,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
2... |
NCT03085485 | 62:68:treatment | Subjects taking moderate or strong inhibitors or inducers of CYP3A4 | 2 | [
"Subjects",
"taking",
"moderate",
"or",
"strong",
"inhibitors",
"or",
"inducers",
"of",
"CYP3A4"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02538198 | ,,,248:260:treatment | must either commit to continued abstinence from heterosexual intercourse or begin TWO acceptable methods of birth control, one highly effective method and one additional effective method AT THE SAME TIME, at least 28 days before she starts taking lenalidomide | 2 | [
"must",
"either",
"commit",
"to",
"continued",
"abstinence",
"from",
"heterosexual",
"intercourse",
"or",
"begin",
"TWO",
"acceptable",
"methods",
"of",
"birth",
"control",
",",
"one",
"highly",
"effective",
"method",
"and",
"one",
"additional",
"effective",
"meth... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT00338377 | 3:22:treatment,24:39:treatment,41:52:treatment,54:79:treatment,120:136:chronic_disease,,157:172:treatment,190:216:treatment | A stress cardiac test (stress thallium, stress MUGA, dobutamine echocardiogram or other stress test that will rule out cardiac ischemia) within 6 months of lymphodepletion. (Turnstile II - Chemotherapy/Cell Infusion-Inclusion Criteria) | 2 | [
"A",
"stress",
"cardiac",
"test",
"(",
"stress",
"thallium",
",",
"stress",
"MUGA",
",",
"dobutamine",
"echocardiogram",
"or",
"other",
"stress",
"test",
"that",
"will",
"rule",
"out",
"cardiac",
"ischemia",
")",
"within",
"6",
"months",
"of",
"lymphodepletion... | [
0,
1,
2,
2,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
1,
1,
0,
0
] |
NCT01614197 | 1:29:treatment,,73:98:treatment,105:113:treatment,,129:155:treatment | Hematopoietic growth factors: At least 14 days after the last dose of a long-acting growth factor (e.g. Neulasta) or 7 days for short-acting growth factor | 2 | [
"Hematopoietic",
"growth",
"factors",
":",
"At",
"least",
"14",
"days",
"after",
"the",
"last",
"dose",
"of",
"a",
"long-acting",
"growth",
"factor",
"(",
"e.g",
".",
"Neulasta",
")",
"or",
"7",
"days",
"for",
"short-acting",
"growth",
"factor"
] | [
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
1,
0,
0,
0,
0,
0,
1,
1,
1
] |
NCT03030118 | 28:62:chronic_disease,64:75:chronic_disease,80:91:chronic_disease | Evidence of infection with human immunodeficiency virus (HIV), Hepatitis B, or Hepatitis C | 2 | [
"Evidence",
"of",
"infection",
"with",
"human",
"immunodeficiency",
"virus",
"(",
"HIV",
")",
",",
"Hepatitis",
"B",
",",
"or",
"Hepatitis",
"C"
] | [
0,
0,
0,
0,
2,
2,
2,
2,
0,
0,
0,
2,
2,
0,
0,
0,
0
] |
NCT01809002 | 1:22:chronic_disease | Peripheral Neuropathy | 2 | [
"Peripheral",
"Neuropathy"
] | [
2,
2
] |
NCT01696734 | 1:15:chronic_disease | cardiomyopathy | 2 | [
"cardiomyopathy"
] | [
2
] |
NCT01597518 | 1:20:treatment | Phenylpropanolamine | 2 | [
"Phenylpropanolamine"
] | [
1
] |
NCT02819141 | 34:89:treatment | currently receiving a continuous intravenous infusion of a sedative/opioid medication(s) | 2 | [
"currently",
"receiving",
"a",
"continuous",
"intravenous",
"infusion",
"of",
"a",
"sedative/opioid",
"medication",
"(",
"s",
")"
] | [
0,
0,
0,
0,
1,
1,
1,
1,
1,
1,
0,
0,
0
] |
NCT02531880 | 29:41:cancer,42:48:chronic_disease,117:125:treatment | Brain abnormality such as a brain tumor, stroke, brain damage from head trauma or blood vessel abnormalities, on an MRI scan | 2 | [
"Brain",
"abnormality",
"such",
"as",
"a",
"brain",
"tumor",
",",
"stroke",
",",
"brain",
"damage",
"from",
"head",
"trauma",
"or",
"blood",
"vessel",
"abnormalities",
",",
"on",
"an",
"MRI",
"scan"
] | [
0,
0,
0,
0,
0,
3,
3,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT00975520 | 26:54:cancer | Histologically confirmed neurotropic primary melanoma | 2 | [
"Histologically",
"confirmed",
"neurotropic",
"primary",
"melanoma"
] | [
0,
0,
3,
3,
3
] |
NCT02089607 | 24:38:chronic_disease | Left (or right) common carotid artery | 2 | [
"Left",
"(",
"or",
"right",
")",
"common",
"carotid",
"artery"
] | [
0,
0,
0,
0,
0,
0,
2,
2
] |
NCT00472329 | 1:18:chronic_disease | Organ dysfunction felt to be due to the conditioning for the first transplant | 2 | [
"Organ",
"dysfunction",
"felt",
"to",
"be",
"due",
"to",
"the",
"conditioning",
"for",
"the",
"first",
"transplant"
] | [
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01599559 | 1:19:chronic_disease,46:54:cancer,114:129:chronic_disease | Cardiac impairment due to local extension of lymphoma will not be an exclusion criterion in the absence of other cardiac disease | 2 | [
"Cardiac",
"impairment",
"due",
"to",
"local",
"extension",
"of",
"lymphoma",
"will",
"not",
"be",
"an",
"exclusion",
"criterion",
"in",
"the",
"absence",
"of",
"other",
"cardiac",
"disease"
] | [
2,
2,
0,
0,
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2
] |
NCT02161380 | 34:40:cancer, | Patients with a prior history of cancer will need documentation from their cancer specialist that the cancer was cured at least 5 years before study entry | 2 | [
"Patients",
"with",
"a",
"prior",
"history",
"of",
"cancer",
"will",
"need",
"documentation",
"from",
"their",
"cancer",
"specialist",
"that",
"the",
"cancer",
"was",
"cured",
"at",
"least",
"5",
"years",
"before",
"study",
"entry"
] | [
0,
0,
0,
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03090672 | 12:43:chronic_disease | History of severe traumatic brain injuries | 2 | [
"History",
"of",
"severe",
"traumatic",
"brain",
"injuries"
] | [
0,
0,
2,
2,
2,
2
] |
NCT00085982 | ,,,85:97:treatment | 2 hour plasma glucose >= 200 mg/dL following a 75 gram (1.75g/kg if less than 40kg) oral glucose load | 2 | [
"2",
"hour",
"plasma",
"glucose",
">",
"=",
"200",
"mg/dL",
"following",
"a",
"75",
"gram",
"(",
"1.75g/kg",
"if",
"less",
"than",
"40kg",
")",
"oral",
"glucose",
"load"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0
] |
NCT02498613 | 45:67:treatment, | Patients should not have received any other investigational agents within the past 4 weeks | 2 | [
"Patients",
"should",
"not",
"have",
"received",
"any",
"other",
"investigational",
"agents",
"within",
"the",
"past",
"4",
"weeks"
] | [
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0
] |
NCT02985801 | 12:37:cancer | Underlying pancreatic adenocarcinoma | 2 | [
"Underlying",
"pancreatic",
"adenocarcinoma"
] | [
0,
3,
3
] |
NCT02465060 | 9:24:treatment | Chronic inhaled steroid use | 2 | [
"Chronic",
"inhaled",
"steroid",
"use"
] | [
0,
1,
1,
0
] |
NCT02945293 | 1:16:chronic_disease | unstable angina | 2 | [
"unstable",
"angina"
] | [
2,
2
] |
NCT02514083 | 1:14:chronic_disease | HIV infection | 2 | [
"HIV",
"infection"
] | [
2,
2
] |
NCT00716066 | 1:33:chronic_disease,35:51:chronic_disease,53:68:chronic_disease,70:78:chronic_disease,80:96:chronic_disease,98:112:chronic_disease | Autoimmune peripheral neuropathy (anti-Hu [Anna-1], anti-GM1 [GD1b], anti-MAG, anti-ganglioside, anti-sulfatide) | 2 | [
"Autoimmune",
"peripheral",
"neuropathy",
"(",
"anti-Hu",
"[",
"Anna-1",
"]",
",",
"anti-GM1",
"[",
"GD1b",
"]",
",",
"anti-MAG",
",",
"anti-ganglioside",
",",
"anti-sulfatide",
")"
] | [
2,
2,
2,
0,
2,
2,
0,
0,
0,
2,
2,
0,
0,
0,
2,
0,
2,
0,
2,
0
] |
NCT02911831 | 57:63:cancer | Patients currently undergoing treatment for any type of cancer | 2 | [
"Patients",
"currently",
"undergoing",
"treatment",
"for",
"any",
"type",
"of",
"cancer"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
3
] |
NCT01807897 | 24:45:chronic_disease, | Physician diagnosis of chronic heart failure, American Heart Association Stage C-D | 2 | [
"Physician",
"diagnosis",
"of",
"chronic",
"heart",
"failure",
",",
"American",
"Heart",
"Association",
"Stage",
"C-D"
] | [
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0
] |
NCT02769000 | 56:62:chronic_disease | Clinically or radiographically significant evidence of stroke | 2 | [
"Clinically",
"or",
"radiographically",
"significant",
"evidence",
"of",
"stroke"
] | [
0,
0,
0,
0,
0,
0,
2
] |
NCT03093272 | 1:26:chronic_disease | Gastrointestinal disorder affecting absorption | 2 | [
"Gastrointestinal",
"disorder",
"affecting",
"absorption"
] | [
2,
2,
0,
0
] |
NCT01962415 | 1:24:chronic_disease | Hurler syndrome (MPS I) | 2 | [
"Hurler",
"syndrome",
"(",
"MPS",
"I",
")"
] | [
2,
2,
2,
2,
0,
0
] |
NCT02634957 | 12:28:chronic_disease | History of systemic illness that could affect wound healing | 2 | [
"History",
"of",
"systemic",
"illness",
"that",
"could",
"affect",
"wound",
"healing"
] | [
0,
0,
2,
2,
0,
0,
0,
0,
0
] |
NCT02138617 | ,,,48:67:treatment,,, | patients discovered to have ≥2+ proteinuria on dipstick urinalysis at baseline should undergo a 24 hour urine collection and must demonstrate ≤ 1g of protein in 24 hours | 2 | [
"patients",
"discovered",
"to",
"have",
"≥2+",
"proteinuria",
"on",
"dipstick",
"urinalysis",
"at",
"baseline",
"should",
"undergo",
"a",
"24",
"hour",
"urine",
"collection",
"and",
"must",
"demonstrate",
"≤",
"1g",
"of",
"protein",
"in",
"24",
"hours"
] | [
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02464878 | 12:34:treatment, | Use of any investigational agents within 4 weeks of enrollment | 2 | [
"Use",
"of",
"any",
"investigational",
"agents",
"within",
"4",
"weeks",
"of",
"enrollment"
] | [
0,
0,
0,
1,
1,
0,
0,
0,
0,
0
] |
NCT02273375 | 1:66:treatment | Pre-operative (neo-adjuvant) platinum based or other chemotherapy is not permissible | 2 | [
"Pre-operative",
"(",
"neo-adjuvant",
")",
"platinum",
"based",
"or",
"other",
"chemotherapy",
"is",
"not",
"permissible"
] | [
1,
1,
1,
1,
1,
1,
1,
0,
0,
0,
0,
0
] |
NCT02865135 | 1:17:chronic_disease,25:28:chronic_disease,63:88:treatment,134:149:treatment | Active hepatitis, known HIV, or other condition that requires immunosuppressive therapy, including current use of high dose systemic corticosteroids | 2 | [
"Active",
"hepatitis",
",",
"known",
"HIV",
",",
"or",
"other",
"condition",
"that",
"requires",
"immunosuppressive",
"therapy",
",",
"including",
"current",
"use",
"of",
"high",
"dose",
"systemic",
"corticosteroids"
] | [
2,
2,
0,
0,
2,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02781701 | 44:47:chronic_disease,,, | At home confirmation of moderate to severe OSA (AHI 15-60) | 2 | [
"At",
"home",
"confirmation",
"of",
"moderate",
"to",
"severe",
"OSA",
"(",
"AHI",
"15-60",
")"
] | [
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
0,
0
] |
NCT02516696 | 19:32:chronic_disease | Subject has known HIV infection | 2 | [
"Subject",
"has",
"known",
"HIV",
"infection"
] | [
0,
0,
0,
2,
2
] |
NCT02436408 | 1:9:chronic_disease | Dementia or significantly altered mental status that would prohibit the understanding or rendering of informed consent and compliance with the requirements of this protocol | 2 | [
"Dementia",
"or",
"significantly",
"altered",
"mental",
"status",
"that",
"would",
"prohibit",
"the",
"understanding",
"or",
"rendering",
"of",
"informed",
"consent",
"and",
"compliance",
"with",
"the",
"requirements",
"of",
"this",
"protocol"
] | [
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02567422 | 13:23:treatment,37:55:treatment,90:99:treatment | Patients on tacrolimus or any other immunosuppressants with significant interaction with cisplatin | 2 | [
"Patients",
"on",
"tacrolimus",
"or",
"any",
"other",
"immunosuppressants",
"with",
"significant",
"interaction",
"with",
"cisplatin"
] | [
0,
0,
1,
0,
0,
0,
1,
0,
0,
0,
0,
1
] |
NCT03066596 | ,35:41:chronic_disease | in past month, > 2 days/week with asthma symptoms | 2 | [
"in",
"past",
"month",
",",
">",
"2",
"days/week",
"with",
"asthma",
"symptoms"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
2,
0
] |
NCT02815917 | 8:35:treatment, | Use of dopaminergic CNS stimulants (prescription, over-the counter or recreational drugs) within 30 days of screening intake visit, as assessed by review of health history form and concomitant medication review at screening intake visit (from medical record and/or self-reported) that are deemed by a physician investiga... | 2 | [
"Use",
"of",
"dopaminergic",
"CNS",
"stimulants",
"(",
"prescription",
",",
"over-the",
"counter",
"or",
"recreational",
"drugs",
")",
"within",
"30",
"days",
"of",
"screening",
"intake",
"visit",
",",
"as",
"assessed",
"by",
"review",
"of",
"health",
"history... | [
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0... |
NCT02101034 | ,,56:71:cancer, | Alkaline phosphatase ≤ 2.5 x IULN for patients without bone metastases and ≤ 5.0 x IULN for patients with bone metastases | 2 | [
"Alkaline",
"phosphatase",
"≤",
"2.5",
"x",
"IULN",
"for",
"patients",
"without",
"bone",
"metastases",
"and",
"≤",
"5.0",
"x",
"IULN",
"for",
"patients",
"with",
"bone",
"metastases"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02592551 | 77:93:chronic_disease,107:131:chronic_disease,146:158:chronic_disease,160:184:chronic_disease,186:204:chronic_disease,213:233:chronic_disease,237:246:chronic_disease,255:273:chronic_disease,322:350:chronic_disease,352:363:chronic_disease,367:401:chronic_disease,406:443:chronic_disease | Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, uncontrolled hypertension, unstable angina pectoris, cardiac arrhythmia, active peptic ulcer disease or gastritis, active bleeding diatheses including any subject known to have evidence of... | 2 | [
"Uncontrolled",
"intercurrent",
"illness",
"including",
",",
"but",
"not",
"limited",
"to",
",",
"ongoing",
"or",
"active",
"infection",
",",
"symptomatic",
"congestive",
"heart",
"failure",
",",
"uncontrolled",
"hypertension",
",",
"unstable",
"angina",
"pectoris",... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
2,
2,
2,
0,
0,
2,
0,
2,
2,
2,
0,
2,
2,
0,
0,
2,
2,
2,
0,
2,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
2,
2,
0,
0,
0,
0,
2,
2,
2,
2,
0,
0,
0... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.